149 related articles for article (PubMed ID: 8777919)
1. The effect of human growth hormone therapy on L-(methyl-2H3)-leucine turnover and urinary pseudouridine concentration in patients with Ullrich-Turner syndrome.
Böhles H; Brendel L; Förster H; Träger K; Vogt J; Georgieff M
Eur J Pediatr; 1996 Apr; 155(4):275-80. PubMed ID: 8777919
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone deficiency and growth hormone therapy in Ullrich-Turner-syndrome.
Butenandt O
Klin Wochenschr; 1980 Jan; 58(2):99-101. PubMed ID: 7366123
[TBL] [Abstract][Full Text] [Related]
3. Treatment of patients with Ullrich-Turner syndrome with conventional doses of growth hormone and the combination with testosterone or oxandrolone: effect on growth, IGF-I and IGFBP-3 concentrations.
Haeusler G; Frisch H; Schmitt K; Blümel P; Plöchl E; Zachmann M; Waldhör T
Eur J Pediatr; 1995 Jun; 154(6):437-44. PubMed ID: 7545577
[TBL] [Abstract][Full Text] [Related]
4. Recombinant growth hormone in children and adolescents with Turner syndrome.
Cave CB; Bryant J; Milne R
Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
[TBL] [Abstract][Full Text] [Related]
5. Combination growth hormone and estrogen increase bone mineralization in girls with Turner syndrome.
Beckett PR; Copeland KC; Flannery TK; Sherman LD; Abrams SA
Pediatr Res; 1999 May; 45(5 Pt 1):709-13. PubMed ID: 10231869
[TBL] [Abstract][Full Text] [Related]
6. Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome.
Rosenfeld RG; Frane J; Attie KM; Brasel JA; Burstein S; Cara JF; Chernausek S; Gotlin RW; Kuntze J; Lippe BM
J Pediatr; 1992 Jul; 121(1):49-55. PubMed ID: 1625092
[TBL] [Abstract][Full Text] [Related]
7. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial.
Rosenfeld RG; Hintz RL; Johanson AJ; Brasel JA; Burstein S; Chernausek SD; Clabots T; Frane J; Gotlin RW; Kuntze J
J Pediatr; 1986 Dec; 109(6):936-43. PubMed ID: 3537249
[TBL] [Abstract][Full Text] [Related]
8. Growth-stimulating effects of human growth hormone therapy in patients with Turner syndrome.
Raiti S; Moore WV; Van Vliet G; Kaplan SL
J Pediatr; 1986 Dec; 109(6):944-9. PubMed ID: 3537250
[TBL] [Abstract][Full Text] [Related]
9. [The current treatment concept of Turner syndrome].
Blümel P; Stögmann W
Padiatr Padol; 1989; 24(1):81-9. PubMed ID: 2654820
[TBL] [Abstract][Full Text] [Related]
10. The growth pattern and final height of girls with Turner syndrome with and without human growth hormone treatment.
Dacou-Voutetakis C; Karavanaki-Karanassiou K; Petrou V; Georgopoulos N; Maniati-Christidi M; Mavrou A
Pediatrics; 1998 Apr; 101(4 Pt 1):663-8. PubMed ID: 9521953
[TBL] [Abstract][Full Text] [Related]
11. [Therapy for short stature in girls with Turner syndrome].
Ning G; Xie S
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):396-8. PubMed ID: 12545844
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections.
Sas T; de Muinck Keizer-Schrama S; Aanstoot HJ; Stijnen T; Drop S
Clin Endocrinol (Oxf); 2000 Jun; 52(6):741-7. PubMed ID: 10848879
[TBL] [Abstract][Full Text] [Related]
13. The influence of growth hormone monotherapy and growth hormone in combination with oxandrolone or testosterone on thyroxid hormone parameters and thyroxine binding globulin in patients with Ullrich-Turner syndrome.
Schmitt K; Häusler G; Blümel P; Plöchl E; Waldhör T; Frisch H
Eur J Pediatr; 1997 Feb; 156(2):99-103. PubMed ID: 9039510
[TBL] [Abstract][Full Text] [Related]
14. Body weight in children with Turner syndrome treated with growth hormone.
Corel LJ; Van den Broeck J; Rongen-Westerlaken C; Massa G; Wit JM
Int J Obes Relat Metab Disord; 1996 Oct; 20(10):957-62. PubMed ID: 8910102
[TBL] [Abstract][Full Text] [Related]
15. The correlation of the IGF-I, IGFBP-3, and ALS generation test to height velocity after 6 months of recombinant growth hormone therapy in girls with Turner syndrome.
Collett-Solberg PF; Pessoa de Queiroz AN; Cardoso ME; Jusan RC; Vaisman M; Guimarães MM
Growth Horm IGF Res; 2006 Aug; 16(4):240-6. PubMed ID: 16908209
[TBL] [Abstract][Full Text] [Related]
16. Low urinary growth hormone values in patients with Turner's syndrome.
Kohno H; Honda S
J Clin Endocrinol Metab; 1992 Mar; 74(3):619-22. PubMed ID: 1740496
[TBL] [Abstract][Full Text] [Related]
17. Non-conventional growth hormone therapy in Turner syndrome: the United States experience.
Rosenfeld RG
Horm Res; 1990; 33(2-4):137-40; discussion 140-2. PubMed ID: 2210618
[TBL] [Abstract][Full Text] [Related]
18. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
van Teunenbroek A; de Muinck Keizer-Schrama S; Stijnen T; Waelkens J; Wit JM; Vulsma T; Gerver WJ; Reeser H; Delemarre-van de Waal H; Jansen M; Drop S
Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
[TBL] [Abstract][Full Text] [Related]
19. Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome.
Rosenfeld RG; Hintz RL; Johanson AJ; Sherman B; Brasel JA; Burstein S; Chernausek S; Compton P; Frane J; Gotlin RW
J Pediatr; 1988 Aug; 113(2):393-400. PubMed ID: 3397807
[TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human growth hormone on urinary 15N-nitrogen balance in girls with Turner syndrome as compared to children with growth hormone deficiency.
Rother K; Zachmann M; Kempken B; Grüters A; Schnabel D; L'Allemand D; Häusler G; Frisch H
Horm Res; 1989; 32(5-6):166-9. PubMed ID: 2634609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
